Kathryn Gregory
Direktor/Vorstandsmitglied bei DEVONIAN HEALTH GROUP INC.
Vermögen: 14 059 $ am 30.04.2024
Aktive Positionen von Kathryn Gregory
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ANTENGENE CORPORATION LIMITED | Corporate Officer/Principal | 25.05.2021 | - |
CARMELL CORPORATION | Direktor/Vorstandsmitglied | - | - |
Independent Dir/Board Member | - | - | |
DEVONIAN HEALTH GROUP INC. | Direktor/Vorstandsmitglied | 28.02.2024 | - |
Karriereverlauf von Kathryn Gregory
Ehemalige bekannte Positionen von Kathryn Gregory
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Kg Biopharma Consulting LLC
Kg Biopharma Consulting LLC Miscellaneous Commercial ServicesCommercial Services Kg Biopharma Consulting LLC provides strategic advisory services. The private company is based in Wilton, CT. | Präsident | 01.03.2018 | 01.02.2019 |
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01.09.2017 | 01.02.2018 |
Seneb Biosciences, Inc. | Vorstandsvorsitzender | 01.04.2009 | 01.12.2017 |
Gründer | 01.04.2009 | 01.12.2017 | |
Purdue Pharma LP
Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Corporate Officer/Principal | 01.02.2015 | 01.03.2017 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 01.12.2012 | 01.02.2015 |
Neose Technologies, Inc.
Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | Corporate Officer/Principal | 01.01.1999 | 08.07.2010 |
░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Kathryn Gregory
University of California, Berkeley | Undergraduate Degree |
Pepperdine University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 13 |
Vereinigtes Königreich | 3 |
China | 2 |
Operativ
Corporate Officer/Principal | 10 |
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 11 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
AILERON THERAPEUTICS, INC. | Health Technology |
ANTENGENE CORPORATION LIMITED | Health Technology |
CARMELL CORPORATION | Health Technology |
DEVONIAN HEALTH GROUP INC. | Health Technology |
Private Unternehmen | 9 |
---|---|
Neose Technologies, Inc.
Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | Health Technology |
Cytel Corp. | |
Gensia Sicor Pharmaceuticals, Inc. | |
Teva Pharmaceuticals Ltd.
Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom. | Health Technology |
Purdue Pharma LP
Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
Kg Biopharma Consulting LLC
Kg Biopharma Consulting LLC Miscellaneous Commercial ServicesCommercial Services Kg Biopharma Consulting LLC provides strategic advisory services. The private company is based in Wilton, CT. | Commercial Services |
Seneb Biosciences, Inc. |
- Börse
- Insiders
- Kathryn Gregory
- Erfahrung